These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30773273)

  • 1. Control and prevention of invasive pneumococcal disease in Taiwan: Current achievements and future challenges.
    Su WJ; Yang CH
    J Formos Med Assoc; 2019 Jun; 118(6):961-964. PubMed ID: 30773273
    [No Abstract]   [Full Text] [Related]  

  • 2. Introduction of pneumococcal conjugate vaccine into the Dutch national immunisation programme.
    van Oosten M; de Greeff SC; Spanjaard L; Schouls LM
    Euro Surveill; 2006 Jun; 11(6):E060608.2. PubMed ID: 16819118
    [No Abstract]   [Full Text] [Related]  

  • 3. Progress in introduction of pneumococcal conjugate vaccine worldwide, 2000–2012.
    Wkly Epidemiol Rec; 2013 Apr; 88(17):173-80. PubMed ID: 23696979
    [No Abstract]   [Full Text] [Related]  

  • 4. Introduction of pneumococcal conjugate vaccine into the Norwegian childhood vaccination programme.
    Bergsaker MA; Feiring B
    Euro Surveill; 2006 Feb; 11(2):E060202.5. PubMed ID: 16804205
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence of invasive pneumococcal disease in children 3 to 36 months of age at a tertiary care pediatric center 2 years after licensure of the pneumococcal conjugate vaccine.
    Lin PL; Michaels MG; Janosky J; Ortenzo M; Wald ER; Mason EO
    Pediatrics; 2003 Apr; 111(4 Pt 1):896-9. PubMed ID: 12671130
    [No Abstract]   [Full Text] [Related]  

  • 6. Invasive pneumococcal disease and the need for the new 13-valent pneumococcal vaccine.
    Bolton M; Barson W
    Pediatr Ann; 2010 Aug; 39(8):497-503. PubMed ID: 20704146
    [No Abstract]   [Full Text] [Related]  

  • 7. How many is enough? Will conjugated pneumococcal vaccines with more serotypes and fewer doses work better?
    Lu CY; Huang LM
    J Formos Med Assoc; 2011 Feb; 110(2):67-9. PubMed ID: 21377059
    [No Abstract]   [Full Text] [Related]  

  • 8. Introduction of pneumococcal conjugate vaccine to the UK childhood immunisation programme, and changes to the meningitis C and Hib schedules.
    Cameron C; Pebody R
    Euro Surveill; 2006 Mar; 11(3):E060302.4. PubMed ID: 16804223
    [No Abstract]   [Full Text] [Related]  

  • 9. [Incidence of invasive pneumococcal infection in children aged less than two years. The heptavalent pneumococcal conjugate vaccine. Situation in Spain].
    Blanco Quirós A; Giménez Sánchez F; Asensi Botet F; Bernaola Iturbe E; Martín Fde J; García Pérez J; Garcés Sánchez M; Gómez Campderá JA; Picazo JJ; Pineda Solas V;
    An Esp Pediatr; 2002 Oct; 57(4):287-9. PubMed ID: 12392660
    [No Abstract]   [Full Text] [Related]  

  • 10. The future of pneumococcal conjugate vaccines for prevention of pneumococcal diseases in infants and children.
    Pelton SI; Klein JO
    Pediatrics; 2002 Oct; 110(4):805-14. PubMed ID: 12359799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of invasive pneumococcal disease after introduction of the Universal Infant Immunization Program, British Columbia (2002-2005).
    Can Commun Dis Rep; 2006 Jul; 32(14):157-61. PubMed ID: 16869067
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.
    Zangeneh TT; Baracco G; Al-Tawfiq JA
    Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal conjugate vaccine for childhood immunization--WHO position paper.
    Wkly Epidemiol Rec; 2007 Mar; 82(12):93-104. PubMed ID: 17380597
    [No Abstract]   [Full Text] [Related]  

  • 14. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on recommended use of pneumococcal conjugate vaccine.
    National Advisory Committee on Immunization
    Can Commun Dis Rep; 2002 Jan; 28(ACS-2):1-32. PubMed ID: 12728645
    [No Abstract]   [Full Text] [Related]  

  • 15. Pediatric invasive pneumococcal disease in Taiwan following a national catch-up program with the 13-valent pneumococcal conjugate vaccine.
    Wei SH; Chiang CS; Chiu CH; Chou P; Lin TY
    Pediatr Infect Dis J; 2015 Mar; 34(3):e71-7. PubMed ID: 25247584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Conjugate vaccines changed the epidemiology of infection].
    Ecker-Schlipf B
    Med Monatsschr Pharm; 2006 Aug; 29(8):307-8. PubMed ID: 16927601
    [No Abstract]   [Full Text] [Related]  

  • 17. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
    Ingels HA
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-burden of paediatric pneumococcal disease in the UK and the potential cost-effectiveness of prevention using 7-valent pneumococcal conjugate vaccine.
    McIntosh ED; Conway P; Willingham J; Lloyd A
    Vaccine; 2003 Jun; 21(19-20):2564-72. PubMed ID: 12744892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005.
    Harboe ZB; Valentiner-Branth P; Benfield TL; Christensen JJ; Hjuler T; Kaltoft M; Krogfelt KA; Lambertsen L; Konradsen HB
    Vaccine; 2008 Jul; 26(29-30):3765-71. PubMed ID: 18513840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive pneumococcal diseases in Uruguayan children: comparison between serotype distribution and conjugate vaccine formulations.
    Camou T; Palacio R; Di Fabio JL; Hortal M
    Vaccine; 2003 May; 21(17-18):2093-6. PubMed ID: 12706699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.